These observations were confirmed by Hams [77] through the demonstration of increased levels of IL-17E in the lungs of IPF patients, which is correlated, interestingly, with IL-13 release that exacerbates collagen deposition during the IPF process. This evidence concerns the gene IL13 and idiopathic pulmonary fibrosis.